Asrukascript 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
Boryeong Co., Ltd.
MFDS item code 201109315 · Approved 2011.10.31 · Insurance code 641905741
Prevention and maintenance treatment of asthma, relief of symptoms of allergic rhinitis (seasonal and perennial)
This medication helps prevent and continuously treat asthma. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This medicine should be taken once daily. Patients with asthma should take it in the evening, while patients with allergic rhinitis should take it at a time determined according to their condition. Patients with both asthma and allergic rhinitis should take 1 sachet once daily in the evening.
Asthma Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Infants 12 months to under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months to under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This drug may cause significant neuropsychiatric adverse effects, so it is important to closely monitor for changes in mental state such as anxiety, aggression, depression, hallucinations, or suicidal thoughts and behaviors during treatment. This drug should not be used in patients with hypersensitivity to any of its components. During treatment, unusual reactions such as dizziness, headache, abdominal pain, fever, cough, and rash may occur, so consult a doctor if symptoms arise. This drug is not a treatment for acute asthma attacks, so a suitable emergency medication should be available and used when acute symptoms occur. Inhaled corticosteroids should not be abruptly discontinued or replaced with this drug; they should be adjusted gradually according to a physician's instructions. It should not be used alone for the treatment of exercise-induced bronchospasm; if needed, inhaled β-agonists should be used in conjunction. Patients with a hypersensitivity to aspirin should avoid taking aspirin or non-steroidal anti-inflammatory drugs while on this medication, as this drug does not treat aspirin-induced bronchoconstriction. Serious symptoms, such as vasculitis or eosinophilia, may rarely occur during treatment, so any indications such as skin rash or worsening respiratory symptoms should be immediately reported to a doctor for monitoring. No specific interactions have been reported with other medications, but monitoring by a doctor may be required when taken with certain drugs. During pregnancy, this drug should only be used when necessary, and caution should be exercised while breastfeeding. It can also be used in children and elderly patients, but safety and efficacy may vary by age group and should be determined according to a physician's instructions. No specific antidote is available for overdose; general symptomatic treatment and clinical monitoring are required. Being sensitive to light, it is important not to open the packaging until just before use, and it should be taken immediately after preparation. Store out of reach of children, and it is advisable not to transfer to another container. This drug should be taken consistently even when asthma symptoms are absent, and if symptoms worsen or unusual symptoms appear, consult with the attending physician. If the frequency of short-acting inhaled bronchodilator use increases during treatment, medical evaluation is necessary. Patients with exercise-induced asthma should continue to use inhaled β-agonists as prescribed for preventive purposes and keep a rescue short-acting inhaler on hand at all times. If neuropsychiatric symptoms occur during treatment, inform a doctor immediately.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to moisture and light, so it is important to store it at room temperature between 1 degree and 30 degrees Celsius. Additionally, it should be kept in a tightly sealed container to prevent air exposure.
Homogeneous granules that are white and free from foreign substances
28 sachets/box [(4 mg/sachet x 28)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
Boryeong Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.